Stock market today: Dow notches record high after strong jobs report eases slowdown worries
Odds of a 50 basis point cut dropped to 0% from 53% last week after the strong September jobs report, according to the CME ...
3 bullish catalysts could keep the bull rally alive and boost stocks 13% in the coming year, research firm says
If the economy steers clear of a recession, a Fed policy error, and external shocks, there's no reason stocks won't climb ...
Chinese stocks could rally 15% as more stimulus spurs a GDP growth spurt next year, SocGen says
Fiscal stimulus in China could help boost the world's second-largest economy to 5% GDP growth next year, SocGen analysts ...
There's a simple reason one of Wall Street's most bullish strategists expects a 40% rise in the S&P 500 by 2030
"EPS could double to $400 by the end of the decade in our Roaring 2020s scenario," Ed Yardeni said in a recent note.
Medicare shake-up sends Humana stock down 23% in a week for its worst drop since 2009
Medicare plans to downgrade ratings on some of the Humana's health insurance plans. The stock has fallen 23% for its worst ...
Stock market today: US stocks jump after blowout September jobs report
"On the face of this the Fed should be hiking rates with these sorts of figures, not cutting rates," Economist James ...
Monroe® Introduces New Heavy Duty Chassis: A New Line of Drag Links and Tie Rods Engineered for Performance
SOUTHFIELD, Mich., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Monroe® proudly announces the launch of its new Heavy Duty Chassis ...
VERB Stockholders Vote To Reverse Split VERB Shares To Retain Nasdaq Listing
Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), the leader in interactive video-based sales-enablement applications, including MARKET.live, its livestream social shopping ...
PDD Holdings: Aggressive Growth and Market Expansion Justify Buy Rating and Raised Target Price
PDD Holdings (PDD – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst today. Analyst Sachin ...
Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will ...
Marvell Stock Buy Recommendation: Capitalizing on AI Potential and Strong Growth Outlook
In a report released yesterday, Atif Malik from Citi maintained a Buy rating on Marvell (MRVL – Research Report), with a price target of ...
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today ...